IDF Premium courses

Specialists

A customised set of modules targeted at endocrinologists, diabetologists, consultants and equivalent.

uems

13 欧洲CME信贷

4.7 (691)

已入學:

1326 學習者

次瀏覽:

64815

IDF Premium courses

选择你的语言

关于本课程

This course will provide diabetologists, endocrinologists, consultants and equivalent specialists with the latest advances in treatment and management of diabetes, and help them to deal more efficiently in day to day clinical practice.

Who is this course for?

Diabetologists, Endocrinologists, Nephrologist Cardiologist, Internist, Neurologist, Ophthalmologist, OBGYN, General surgeon, Orthopaedic surgeon, Consultants and equivalent.

课程

初始自我评估

请完成此操作以继续尝试模块

Learning Objectives:

At the end of this module the learner will be able to:

  • Provide a brief overview of diabetes
  • List the different types of diabetes
  • Discuss the epidemiology of diabetes
  • Describe the physiology of glucose metabolism
  • Discuss the potential factors that increase the risk for getting T2DM and gestational diabetes
  • Review the pathogenesis of diabetes and related symptoms
Learning Objectives:

At the end of this module the learner will be able to:

  • Describe the screening and diagnostic criteria for prediabetes and diabetes
  • Describe the glycaemic targets in different populations
  • Discuss lifestyle intervention for the management of diabetes
Learning Objectives:

At the end of this module the learner will be able to:

  • Describe the pharmacology of oral glucose-lowering medications in diabetes
  • Describe the application of various oral glucose-lowering medications such as metformin, sulphonylureas, alpha-glucosidase inhibitors and thiazolidinediones in clinical practice
  • Discuss the guidelines-based approach in choosing oral glucose-lowering medications in the management of diabetes
Learning Objectives:

At the end of this module the learner will be able to:

  • Discuss the pharmacology of oral glucose-lowering medications in diabetes
  • Describe the clinical application of various oral glucose-lowering medications including gliptins (dipeptidyl peptidase-4 inhibitor), glucagon-like peptide-1 (GLP-1) receptor agonist, sodium-glucose cotransporter-2 (SGLT-2) inhibitors in clinical practice
  • Discuss guidelines-based approach in choosing oral glucose-lowering medications in the management of diabetes
Learning Objectives:

At the end of this module the learner will be able to:

  • Understand the natural history of type 2 diabetes mellitus
  • Identify the indications for insulin treatment
  • Explain the initiation of insulin therapy
  • Describe the indications for insulin intensification
  • Discuss the various insulin intensification regimens and their administration
Learning Objectives:

At the end of this module the learner will be able to:

  • Discuss insulin therapy in diabetes management
  • Identify the pharmacological characteristics and differences between the various types of insulin
  • Discuss the challenges of insulin therapy
  • List the currently available modalities to deliver insulin
  • Evaluate the newer formulations of insulin
Learning Objectives:

At the end of this module the learner will be able to:

  • Describe the pathophysiology of acute complications of diabetes.
  • Enlist the characteristic features of the acute complications of diabetes.
  • Interpret the diagnosis of the acute complications of diabetes.
  • Explain the management of the acute complications of diabetes.
  • Discuss how the acute complications of diabetes may be prevented.
Learning Objectives:

At the end of this module the learner will be able to:

  • Discuss the overview of diabetes and cardiovascular disease.
  • Review the different types of cardiovascular complications.
  • Describe the pathophysiology of cardiovascular complications in diabetes.
  • Discuss the epidemiology of coronary heart disease, cerebrovascular disease and peripheral vascular disease.
  • List the potential risk factors associated with cardiovascular complications.
  • Identify the screening and diagnostic tests for detecting cardiovascular complications in people with diabetes.
  • Discuss the management strategies for cardiovascular complications.
Learning Objectives:

At the end of this module the learner will be able to:

  • Describe diabetic retinopathy and its complications.
  • Enlist the risk factors and pathophysiology of diabetic retinopathy.
  • Classify stages of diabetic retinopathy and diabetic macular oedema.
  • Analyse the management strategies of diabetic retinopathy.
  • Comprehend the treatment recommendations for diabetic retinopathy.
Learning Objectives:

At the end of this module the learner will be able to:

  • Describe the epidemiology and clinical presentations of diabetic polyneuropathy and autonomic neuropathy
  • Understand the screening and diagnostic approach for diabetic polyneuropathy and autonomic neuropathy
  • Describe the preventive and management strategies for diabetic polyneuropathy and autonomic neuropathy
  • Recognise less common types of diabetic neuropathy
Learning Objectives:

At the end of this module the learner will be able to:

  • Provide a brief overview of diabetic kidney disease
  • Discuss the global prevalence of diabetic kidney disease
  • Identify the potential risk factors associated with the development of diabetic kidney disease
  • Describe the pathophysiology of diabetic kidney disease.
  • Review the screening and diagnostic tests for detecting diabetic kidney disease
  • Discuss the guideline recommendations in the management of diabetic kidney disease
Learning Objectives:

At the end of this module the learner will be able to:

  • Describe the epidemiological trend of gestational diabetes mellitus
  • Discuss screening methods for gestational diabetes mellitus
  • Describe the clinical manifestation and recommendations for standard of care in gestational diabetes mellitus
  • Describe the management of gestational diabetes mellitus
Learning Objectives:

At the end of this module the learner will be able to:

  • Discuss the global prevalence of women with preexisting type 1 and 2 diabetes
  • Describe the maternal and foetal complications related to preexisting diabetes
  • List the steps involved in preconception care and counselling
  • Discuss the management of type 1 and 2 diabetes during pregnancy
  • Discuss the management strategies of peri- and post-partum care

请填写此自我评估表以继续

An IDF ‘Certificate of Achievement’ will be awarded to learners who complete all course modules and pass the final assessment with a score of at least 80%. A ‘Certificate of Participation’ will be awarded to learners who score less than 80% in the final assessment after second attempt.

请在继续打印完成证书之前提供反馈

您可以在此处下载或打印具有唯一证书编号的证书。

coc courses

怎么运行的

证书

Leaners who complete all the course modules and the final assessment will receive an offical IDF Certificate and thirtheen European CME credits.

An IDF ‘Certificate of Achievement’ will be awarded to learners who complete all course modules and pass the final assessment with a score of at least 80%. An IDF ‘Certificate of Participation’ will be awarded to learners who score less than 80% in the final assessment after second attempt.

课程费用

Country Category Specialists
低收入国家(LIC)* 200€
其他 300€

*Low-income countries (LIC) are categorized as per the World Bank Classification.

If you are unsure of the income-category of your country, you can check it here.

If you need assistance, please contact us.

4.7

平均评分

(691 评级)
  • 75%
  • 22%
  • 2%
  • 0%
  • 0%
课程详情
模組:

13

课程持续时间:

14 hours

Approx. 5 weeks to complete
Suggest 3 hours/week

课程费用:

低收入国家(LIC) : 200€
其他: 300€

:

English

课程特色

自定進度的靈活學習

实例探究

可下载的资料链接

证书

欧洲CME信贷

© 2022 - IDF - All Right Reserved | Privacy Policy 

Facebook
Twitter
Linkedin